Boston Scientific Corporation (LON:0HOY)
92.39
-1.56 (-1.66%)
Jan 29, 2026, 5:09 PM GMT
Boston Scientific Market Cap
Boston Scientific has a market cap or net worth of 100.98 billion as of January 29, 2026. Its market cap has decreased by -11.95% in one year.
Market Cap
100.98B
Enterprise Value
108.97B
Revenue
14.39B
Ranking
n/a
PE Ratio
48.64
Stock Price
92.39
Market Cap Chart
Since May 19, 1992, Boston Scientific's market cap has increased from 876.49M to 100.98B, an increase of 11,421.46%. That is a compound annual growth rate of 15.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 100.98B | -3.85% |
| Dec 31, 2025 | 105.02B | -0.12% |
| Dec 31, 2024 | 105.15B | 58.15% |
| Dec 29, 2023 | 66.49B | 20.88% |
| Dec 30, 2022 | 55.00B | 23.04% |
| Dec 31, 2021 | 44.71B | 18.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.50B |
| GSK plc | 72.92B |
| Haleon | 33.18B |
| Smith & Nephew | 10.43B |
| Convatec Group | 4.47B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.03B |
| HUTCHMED (China) | 1.89B |